About Synapse Medicine
⚡️ Our latest news
<aside>
📃 Our latest press releases
[Communiqué de Presse] Synapse Medicine lance un Projet de R&D en IA générative de 14,33 Millions d’Euros, soutenu par l’Etat dans le cadre du plan France 2030
[Communiqué de Presse] Synapse Medicine révolutionne la prise en charge personnalisée des patients grâce à l’IA générative
[Communiqué de Presse] Synapse Medicine s’allie à icanopée pour simplifier la transition vers l’Ordonnance Numérique
[Communiqué de Presse] La base de données sur les médicaments Thériaque franchit une nouvelle étape en obtenant l’agrément HAS v3
[Communiqué de Presse] Synapse Medicine et CompuGroup Medical annoncent un partenariat pour révolutionner la prescription
Plus de Communiqués de Presse disponibles ici 👉🏼 Blog Synapse
</aside>
💙 About us
- Who we are
- Our Mission
- Our Story
- Our Technology
- Our Solutions
- Our certifications
- Our Values
- Our Co-Founders
- Our Offices
💡Synapse Medicine in numbers
<aside>
📈 Synapse Medicine in figures
- +90 multi-expert employees based in Bordeaux, Paris and New York.
- +300 hospitals using our services in France
- +35k prescribers 🇫🇷 deployed or being deployed (GPs, specialists, dentists, nurses, etc.), i.e. 400k prescriptions per day
- +2k prescribers 🇺🇸 after just a few months on the market
- +30% market share among GPs
- Winner of the i-démo call for projects to launch a €14.33 million R&D project in generative AI, supported by the French government.
</aside>
🚀 Our achievements in public health
<aside>
⚕️ **Covid19-medicaments.com,** a platform for securing medication risks.
- This platform enables citizens with COVID-19 symptoms to quickly check whether a drug is likely to aggravate their symptoms, without having to consult a practitioner.
- More than 1 million French people have used the covid19-medicaments.com platform, recognized by the AI - Talents e-santé prize by the French Ministry of Health.
</aside>
<aside>
🛡️ Medication Shield, a technology to help manage adverse reactions effects
- Technology dedicated to the automation of pharmacovigilance , deployed by the ANSM in all French CRPVs to help manage the reporting of adverse reactions. reports.
- **40s-2min Time savings
93% AUC* performance**
**Létinier & Al (2022), Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data.*
- The deployment of our Medication Shield technology won the Prix Galien in the e-health category 🏆, considered to be the equivalent of the Nobel Prize in Pharmacy.
- Our Medication Shield technology has received the support of several renowned organizations, including: CHU de Bordeaux, SFPT, CRPVs, ANSM.
</aside>
<aside>
👪 Goodmed, the consumer app that helps with the proper use of medication
- Synapse Medicine's consumer app to better inform and protect French people from adverse drug reactions.
- The app is now used by over 70K people, a figure that is constantly growing.
- Winner of AMI Santé Numérique: 1.3M euros in funding
- To find out more: Goodmed - Espace Presse
</aside>